Evidence map›Paper›PMID 14606065›Full record

ArticleWorld journal of gastroenterology2003

Inhibition of adenovirus-mediated p27kip1 gene on growth of esophageal carcinoma cell strain.

Qing-Ming Wu, Jie-Ping Yu, Qiang Tong, Xiao-Hu Wang, Guo-Jian Xie

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qing-Ming WuDepartment of Gastroenterology, Renmin Hospital of Wuhan University, Hubei Province, China. wuhe9224@sina.com
Jie-Ping Yu
Qiang Tong
Xiao-Hu Wang
Guo-Jian Xie
Taihe Hospital · CNRenmin Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the inhibition of p27kip1 gene on the growth of esophageal carcinoma cell strain (EC9706).

methodsRecombinant adenovirus Ad-p27kip1 was constructed and transfected into esophageal carcinoma cell EC-9706, and its effect on p27kip1 expression, the growth of esophageal carcinoma cell, DNA replication, protein synthesis, cell multiplication and apoptosis were explored by means of cell growth count, 3H-TdR, 3H-Leucine incorporation, flow cytometry, DNA fragment analysis and TUNEL.

resultsRecombinant adenovirus Ad-p27kip1 was successfully constructed with a virus titer of 1.24 X 10(12) pfu/ml. p27kip protein expression increased markedly after EC-9706 transfection, while incorporation quantity of 3H-TdR and 3H-Leucine decreased significantly. The growth of esophageal carcinoma cell was inhibited obviously. Testing of flow cytometry displayed a typical apoptosis peak, and DNA gel electrophoresis showed a typical apoptosis ladder. TUNEL showed the apoptosis rate of Ad-p27kip1 group and control group to be 37.3% and 1.26% (P<0.001) respectively.

conclusionAd-p27kip1 can inhibit the growth and multiplication of esophageal carcinoma cells and induce apoptosis. Therefore, enhanced p27kip1 expression may be a new way to treat esophageal carcinoma.

Indexed as

Esophageal NeoplasmsAdenoviridaeApoptosisCell Cycle ProteinsCell DivisionCell Line, TumorCyclin-Dependent Kinase Inhibitor p27Gene Expression Regulation, NeoplasticHumansIn Situ Nick-End LabelingLeucinePlasmidsPolymerase Chain ReactionThymidineTransfectionTritiumCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27LeucineThymidineTritiumTumor Suppressor Proteins

Identifiers

PMID14606065
PMCPMC4656510
OpenAlexW1563769309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.